daltonism

(redirected from daltonic)
Also found in: Dictionary, Thesaurus, Encyclopedia.

daltonism

 [dawl´ton-izm]
red-green color blindness.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

dal·ton·ism

(dawl'tŏn-izm),
A color vision deficiency, especially deuteranomaly or deuteranopia.
[J. Dalton]
Farlex Partner Medical Dictionary © Farlex 2012

daltonism

also

Daltonism

(dôl′tə-nĭz′əm)
n.
An inherited defect in perception of red and green; red-green colorblindness.

dal·to′ni·an (-tō′nē-ən), dal·ton′ic (-tŏn′ĭk) adj.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

dal·ton·ism

(dawl'tŏn-izm)
Red and green color blindness, transmitted as an X-linked trait.
[John Dalton]
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

daltonism

Term used formerly to designate colour blindness, usually deutan, so named because John Dalton (1766-1844) was the first to describe his own anomaly. See defective colour vision.
Millodot: Dictionary of Optometry and Visual Science, 7th edition. © 2009 Butterworth-Heinemann
References in periodicals archive ?
The Executive Briefings in the April 15, 2001 issue of IBO discussed a German court's ruling against Thermo Electron and in favor of Bruker Daltonics regarding a patent for ion trap mass spectrometers.
Bruker Daltonics struck another blow to Thermo Electron when on April 23, 2001, the US District Court in Boston ruled in favor of Bruker's summary judgment motion of noninfringment of Thermo' US patent No.
Bruker Daltonics and Finnigan Receive Decision on Patent Legislation Billerica, MA, 6/16/99-The Court of Appeals for the Federal Circuit confirmed that Bruker Daltonic's Esquire-LC does not infringe on Finnigan's US Patent 4'540'884, and that while this patent is valid, it narrowly covers the mass sequential instability scan, an older method not used by Bruker Daltonics, according to Bruker Daltonics.
Among smaller-sized companies, Molecular Devices, Bruker Daltonics and Genomic Solutions exhibited the most significant changes in R&D spending as a percentage of sales in 2000.